FR2934492B1 - Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer. - Google Patents
Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer.Info
- Publication number
- FR2934492B1 FR2934492B1 FR0855304A FR0855304A FR2934492B1 FR 2934492 B1 FR2934492 B1 FR 2934492B1 FR 0855304 A FR0855304 A FR 0855304A FR 0855304 A FR0855304 A FR 0855304A FR 2934492 B1 FR2934492 B1 FR 2934492B1
- Authority
- FR
- France
- Prior art keywords
- tlr3
- apoptosis
- ligand
- cancer
- association
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0855304A FR2934492B1 (fr) | 2008-07-31 | 2008-07-31 | Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer. |
PCT/FR2009/051543 WO2010012965A2 (fr) | 2008-07-31 | 2009-07-31 | Association d'un ligand de tlr3 et d'un agent de chimiotherapie agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer |
US13/056,341 US20120045523A1 (en) | 2008-07-31 | 2009-07-31 | Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic "apoptosis" pathway in the treatment of cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0855304A FR2934492B1 (fr) | 2008-07-31 | 2008-07-31 | Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2934492A1 FR2934492A1 (fr) | 2010-02-05 |
FR2934492B1 true FR2934492B1 (fr) | 2012-08-17 |
Family
ID=40380019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0855304A Active FR2934492B1 (fr) | 2008-07-31 | 2008-07-31 | Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer. |
Country Status (3)
Country | Link |
---|---|
US (1) | US20120045523A1 (fr) |
FR (1) | FR2934492B1 (fr) |
WO (1) | WO2010012965A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102369011A (zh) | 2009-03-12 | 2012-03-07 | 健泰科生物技术公司 | 用于治疗造血恶性肿瘤的磷酸肌醇3-激酶抑制剂化合物与化学治疗剂的组合 |
EP2708236A1 (fr) | 2012-09-12 | 2014-03-19 | Medizinische Universität Wien | Traitement de tumeurs |
EP4329761A1 (fr) | 2021-04-28 | 2024-03-06 | ENYO Pharma | Potentialisation forte d'effets d'agonistes de tlr3 à l'aide d'agonistes de fxr en tant que traitement combiné |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2655355C (fr) * | 2006-06-16 | 2014-05-06 | Taisho Pharmaceutical Co., Ltd. | Utilisation d'un inhibiteur de l'expression du gene rpn2 |
-
2008
- 2008-07-31 FR FR0855304A patent/FR2934492B1/fr active Active
-
2009
- 2009-07-31 US US13/056,341 patent/US20120045523A1/en not_active Abandoned
- 2009-07-31 WO PCT/FR2009/051543 patent/WO2010012965A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20120045523A1 (en) | 2012-02-23 |
FR2934492A1 (fr) | 2010-02-05 |
WO2010012965A3 (fr) | 2010-04-15 |
WO2010012965A2 (fr) | 2010-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2886851B1 (fr) | Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee | |
FR2925339B1 (fr) | Medicament pour le traitement du cancer du pancreas | |
DE602005002413D1 (de) | Wegwerfhöschen | |
EP2134400A4 (fr) | Prévention d'une exposition au sang dans les dispositifs à accès vasculaire | |
BRPI0717339A2 (pt) | Reversor de empuxo e nacela de turboélice | |
DK2012872T3 (da) | Behandling af kræft under anvendelse af elektromagnetiske felter i kombination med kræftlægemidler | |
BRPI0906167A2 (pt) | uso de inibidor de serina protease no tratamento de doenças de pele. | |
EP1985302A4 (fr) | Médicament pour le traitement de tumeurs et son utilisation | |
BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
ATE538652T1 (de) | Synergistische pharmazeutische kombination für die behandlung von krebs | |
HK1215683A1 (zh) | 抗葉酸藥在癌症治療中的聯合應用 | |
BRPI0809272A2 (pt) | Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro | |
FR2898636B1 (fr) | Structure de queue-d'aronde de soufflante. | |
CA119210S (en) | Soap basket | |
EP1756166A4 (fr) | Diagnostic et traitement du cancer de la prostate | |
FR2899476B1 (fr) | Association du mazindol dans le traitement du deficit de l'attention/hyperactivite | |
FR2864552B1 (fr) | Traitement de surface par hydroxysulfate | |
FR2896422B1 (fr) | Systeme de drainage pour le traitement de l'hydrocephalie | |
EP1865954A4 (fr) | Methodes pour eviter un oedeme dans le traitement ou la prevention de maladies sensibles a ppar gamma, telles que le cancer | |
ZA201000959B (en) | The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases | |
CL2007003837A1 (es) | Uso de compuestos derivados de isosorbide en la prevencion y/o tratamiento de un trastorno intestinal tal como inflamacion intestinal. | |
FR2934492B1 (fr) | Association d'un ligand de tlr3 et d'un agent agissant sur la voie intrinseque de "l'apoptose" dans le traitement d'un cancer. | |
FR2886852B1 (fr) | Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee | |
DE602006013009D1 (de) | Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs | |
FR2939710B1 (fr) | Systeme de moulage et d'emboitement. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |